Fingerprint
Dive into the research topics of 'Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%
Quang H. Nguyen, Matthew G. McMenemy, Tony Realini, Jess T. Whitson, Stephen M. Goode
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations